PATENT CLAIM ANALYSIS

Application Number: 15893488
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "254090"]

Abstract:
Disclosed herein are compositions and methods for treating cancer, FLT3-AML, and CML.

Claim (Index 62):
The method of  claim 54 , wherein the method further comprises modulating STAT signaling, STAT3, STAT5, MAP kinase signaling, or AKT signaling.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15764724', '15796363', '15242318', '14689682', '15531245']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8174708591968509
- 35 USC 102 Novelty (BERT): 0.5345318972580863
- Combined Prediction Score: 0.7891769630029745
- Mean Citation Score: 359.688486
- Max Citation Score: 364.97186
- Similarity Product: 192.0773635823917

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test